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Objective. Evaluating changes in the power spectral density (PSD) peak frequency of the electrohysterogram (EHG) caused by
nifedipine in women with preterm contractions. Methods. Calculation of the PSD peak frequency in EHG contraction bursts at
diﬀerenttimesofnifedipinetreatmentinwomeningestationalage24to32weekswithcontractions.Results.Asigniﬁcant(P<. 05)
decrease of PSD peak frequency between EHG signals measured before and 15 minutes after administration of nifedipine. A
signiﬁcant(P<. 05)decreaseinPSDpeakfrequencycomparingsignalsrecordedwithin24hoursafteradministrationofnifedipine
to signals 1 day after tocolytic treatment. A higher average PSD peak frequency for patients delivering within 1 week than that for
patients delivering after 1 week from nifedipine treatment (P>. 05). Conclusions. EHG signal analysis has great potential for
quantitative monitoring of uterine contractions. Treatment with nifedipine leads to a shift to lower PSD peak frequency in the
EHG signal.
1.Introduction
Preterm birth is the leading cause of perinatal mortality and
morbidity and accounts for approximately half of preterm
births [1]. Although the management of threatened preterm
labor by tocolytic therapy can prolong gestation [2], eﬀec-
tiveness of tocolytic agents depends on early introduction of
therapy [1]. Some risk factors for preterm delivery have been
identiﬁed, but available prediction methods exhibit poor
diagnostic value for detecting preterm labor at an early stage
[3–5].
When evaluating women with preterm contractions,
the clinicians’ daily dilemma is to diﬀerentiate between
physiological uterine activity and contractions leading to
preterm delivery. Monitoring uterine contractions may
provide important prognostic information during preg-
nancy and parturition. No method is currently available
for non-invasive monitoring and quantiﬁcation of uterine
contractions [3–5].
It is well established that uterine contractions are the
result of the electrical activity propagation through the
uterine muscle cells [6, 7]. The electrohysterogram (EHG) is
a direct measure of the myometrium electrical activity and
it can be measured noninvasively by electrodes positioned
on the maternal abdomen [8–10]. The EHG is characterized
by intermittent “bursts” of action potentials and each burst
corresponds to a mechanical contraction of the uterus.
The uterus is quiescent during pregnancy. However, as
the delivery time approaches, the uterine electrical activity
becomes increasingly synchronous [11].
Some typical changes have been observed in the EHG
properties during preterm and term delivery [12–15]. In
particular, the shifting of the EHG signal energy to higher
frequency as delivery approaches is the most experienced
phenomenon observed in the literature [11–14, 16]. In
particular, the peak frequency, that is, the frequency corre-
sponding to the maximum of the EHG signal power spectral
density (PSD), is the EHG parameter that is most commonly
tested [17].2 Obstetrics and Gynecology International
As uterine preterm contractions are the most frequently
recognized precursor of preterm delivery, inhibiting contrac-
tions(tocolysis)hasbeenthefocusoftherapeuticapproaches
for prevention of preterm birth.
As the delivery time approaches, the number of cell gap
junctions and voltage-dependant calcium channels increases
and form an electrical syncytium leading to an increased
uterine activity [18]. Currently, nifedipine, which directly
blocks the calcium channel, would be in fact the ﬁrst choice
tocolytic agent to postpone delivery [2, 19]. Nifedipine is
reported to be highly eﬀective [2]; however, no placebo-
controlled trials were performed and nifedipine is not
registeredforuseasatocolyticagent[20].Insomerarecases,
serious maternal side eﬀects are reported due to overdosage
of nifedipine [21]. Therefore, more evidence is needed about
the eﬃcacy and safety of this drug for the inhibition of labor.
The aims of this study are (1) providing further insight
intotheuseoftheelectrohysterogram(EHG)formonitoring
uterine electrical contractions in preterm labor; (2) evaluat-
ingthenifedipine-inducedchangesinPSDpeakfrequencyin
women with preterm contractions.
2.MaterialandMethods
Data were collected at the M´ axima Medical Center, a tertiary
care teaching hospital. The study was approved by the
medical ethical committee of the hospital. All participating
women signed an informed consent.
2.1. EHG Signal Recording. The EHG was recorded by eight
disposable contact Ag-AgCl electrodes (2cm interelectrode
distance) placed on the abdomen as shown in Figure 1.
Prior to electrode attachment the skin was prepared by
gentlerubbingwithﬁneabrasivepaper.Areferenceelectrode
was placed on the left hip. In order to obtain an eﬃcient
rejection of the electromagnetic interference, a driven-right-
leg ground electrode and actively shielded cables were
employed. The EHG signals were recorded and digitized at
1000Hz, 20bit resolution, by an M-PAQ ampliﬁer (Maas-
tricht Instruments Ltd., the Netherlands); a 16-channel
system for physiological measurements with programmable
gain and sampling frequency.
All included patients received nifedipine. For each
patient, the EHG was recorded twice, before and after giving
nifedipine. The period of each recording varied between
20 and 100 minutes per patient. A conventional tocogram
was simultaneously recorded for medical prescription. The
use of the tocogram was not speciﬁcally required for the
study,butwasemployedforconﬁrmingtheEHGcontraction
detection.
2.2. EHG Signal Processing. In order to improve the signal
quality, seven bipolar signals were obtained by subtraction of
the signal recorded at electrode ﬁve (Figure 1). The recorded
signals where then visually inspected to assess the signal
quality. If judged of good quality, all seven channels were
used for further processing.
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Figure 1: Electrode position and numbering on the abdomen.
Prior to electrode positioning, the half length of the uterus was
measured. The interelectrode distance was 2cm for all electrodes.
Ref = reference electrode, DRL = ground electrode.
Additional noise due to respiration, maternal electrocar-
diogram, and skeletal electromyogram caused by abdominal
muscle contraction was removed by band-pass ﬁltering
between 0.34Hz and 1Hz [16]. To this end, a four-order
band-pass Butterworth ﬁlter was employed. The signal was
then downsampled up to 20Hz. The down-sampling was
made possible by the low frequency content of the signal and
reduced signiﬁcantly the computational time. Contraction
bursts of EHG activity were detected on the EHG signal by
the method described in [22] and validated by comparison
with the simultaneously recorded tocogram.
Similarly to many previous studies on the prediction of
pre-term labor by electrohysterography, the power spectral
density (PSD) was calculated on each bipolar signal by
computing the Fast Fourier Transform (FFT) [8, 12, 16, 18].
OnlysignalsegmentswithinthedetectedEHGelectricalcon-
traction burst were used and no information derived from
the quiescent period between contractions was analyzed.
The PSD was separately calculated for three contraction
bursts during the ﬁrst period of measurement, before
treatment, and three contraction bursts during the second
period of measurement, after treatment. The frequency at
which the PSD was maximum, that is, the peak frequency
(fP), was singled-out. For each channel, the values of fP
were averaged over the three recorded bursts of electrical
activity. Average and standard deviation of resulting fP for
the diﬀerent periods of recording were then analyzed and
compared.
2.3. Study Population. The study protocol has been carried
out in addition to the general used procedures for threatened
preterm labor.
Women admitted to the hospital for spontaneous
preterm contractions, at risk for extreme preterm delivery,Obstetrics and Gynecology International 3
Table 1: Study population characteristics.
Pt Age
GA
1 at
ﬁrst EHG
recording
Pregnancy BMI
2
Cervical
dilatation
(cm)
Cervical
length
(cm)
PPROM
3 UTI
4
Nifedipine-
recording-
interval
(hours)
Delivery
<1wk
1 29 24 +1 Singleton 22.3 1 3.1 No No 4 No
2 34 28 +0 Singleton 27.8 1 2.3 No No 9 No
3 32 25 +4 Singleton 28.0 0 1.6 No No 10 No
4 29 30 +4 Twin 22.5 1 1.9 No Yes 8 Yes
5 29 31 +2 Twin 21.6 1 2.0 Yes Yes 5 Yes
6 28 29 +5 Twin 27.3 1 2.2 No Yes 0 No
7 34 25 +6 Twin 23.4 2 2.6 Yes Yes 0 No
8 34 31 +1 Singleton 25.1 1 ntb No Yes 0 Yes
1 = gestational age
2 = body mas index
3 = preterm prelabor rupture of membranes
4 = urinary tract infection.
that is, gestational age between 24th and 32nd weeks, were
included in the study.
Exclusion criteria were age under 18 years, body mass
index above 30, cervical dilatation over 3cm. Additionally
were excluded from the study those pregnancies complicated
bypre-eclampsiaorHELLPsyndrome,placentapraevia,fetal
anomalies or maternal trauma precipitating the symptoms.
Immediately after admission to the hospital, patients
were assessed by a clinician in order to evaluate the risk of
preterm delivery. The criteria for preterm labor were regular
contractions at a rate of 4 in 20 minutes or 8 in 1 hour
with at least one of the following: progressive eﬀacement or
dilatation of the cervix over time or dilatation of the cervix
greater than or equal to 2.0cm. If they were judged to be at
risk, they were treated according to the hospital guidelines
following the national guideline for tocolysis of the Dutch
Association for Obstetrics and Gynecology [23].
Three primiparous and ﬁve multiparous women attend-
ing the hospital for preterm contractions underwent mul-
tichannel EHG recording. The mean gestational age on
admission was 28.2 ±2.8w e e k s .
Allsingletonpregnanciesreceivednifedipineoros120mg
daily for the ﬁrst 48 hours. After that, the dosage was lowered
gradually over a 4-day period.
The two twin gestations received nifedipine oros 90mg
as the maximum dosage in order to decrease the risk of
acute lung oedema [24]. Before giving nifedipine oros, in all
pregnancies a load up dose with nifedipine 20 or 40mg was
given. betamethasone for fetal lung maturation was given to
7 patients, in the other patient betamethasone was already
completed in the referring hospital.
Three diﬀerent analyses were done by comparing the
PSD peak frequency among diﬀerent patient groups. The
ﬁrst comparison (three subjects, Group 1) was done between
the value of fP derived from EHG signals recorded before
(Subgroup 1.1) and 15 minutes after administration of
nifedipine (Subgroup 1.2). For those patients who already
started nifedepine treatment in the referring hospital before
the ﬁrst EHG measurement session (three subjects, Group2),
the comparison was done between the ﬁrst measurement,
that is, within 24 hours after starting nifedipine oros 9
(Subgroup 2.1), and one day after ﬁnishing the tocolytic
treatment(Subgroup2.2).Aftertheeﬀects of betamethasone
were expected to be occurred, that is, 48 hours after the
ﬁrst injection, tocolytic treatment was ﬁnished in a cutback
plan over a 4-day period. The third analysis included all
patients (Group3) and aimed at a retrospective comparison
of the fP measured within 24 hours after starting treatment
with nifedipine on women who delivered within one week
(Subgroup 3.1) and the fP measured within 24 hours
after starting treatment with nifedipine on women who
delivered after more than one week (removed: from the EHG
measurement) (Subgroup 3.2).
Of the included patients, ﬁve women were diagnosed
with lower urinary tract infection at 2–4 days before
attending the hospital and four of them were still being
treated with antibiotics when nifedipine was given.
Patient’s characteristics are summarized in Table 1.
2.4. Statistical Analysis. Sigma-Stat software (SPPS Inc,
Chicago, IL) was implemented for statistical comparison of
groups. The PSD peak frequencies in all channels for every
single patient and all separate bursts were considered for
analysis.
Statistical analysis was performed using a 2-tailed t-
student.AP valueoflessthan .05wasconsideredstatistically
signiﬁcant.
3. Results
In all patients, the uterine contractions detected by the
EHG signal analysis corresponded to the uterine mechanical
activity as recorded by tocodynamometer. In Figure 2 an
example of these typical recordings is given for one patient
Ingeneral,thepeakfrequencyaswellastheuterineactiv-
ity decreased in all patients after treatment with nifedipine
(Table 2).4 Obstetrics and Gynecology International
Table 2: Shift of PSD peak frequency.
Group 11 Before nifedipine
(Subgroup 1.1)
15 minutes after nifedipine
(subgroup 1.2) P-value
PDS peak frequency (Hz) 0.367 ±0.061 0.340 ±0.040
0.415 ±0.046 0.375 ±0.051
0.424 ±0.079 0.405 ±0.021
Mean 0.402 ±0.025 0. 373 ±0.026 .043
∗
Group 22
Within 24 hours after
starting nifedipine
(subgroup 2.1)
1 day after ﬁnishing nifedipine
(subgroup 2.2) P-value
PDS peak frequency (Hz) 0.390 ±0.035 0.371 ±0.058
0.436 ±0.046 0.403 ±0.074
0.434 ±0.047 0.403 ±0.041
Mean 0.42 ±0.021 0.392 ±0.015 .024
∗
Group 33
Patients delivering after 1
week after start nifedipine
(subgroup 3.1)
Patients delivering within 1
week after start nifedipine
(subgroup 3.2)
P-value
PDS peak frequency (Hz) 0.340 ±0.040 0.407 ±0.065
0.375 ±0.051 0.380 ±0.055
0.405 ±0.021 0.434 ±0.047
0.436 ±0.046
0.390 ±0.035
Mean 0.389 ±0.031 0.407 ±0.022 .458
∗∗
1 = patient 1–3 (Table 1)
2 = patient 4–6 (Table 1)
3 = patient 1–8 (Table 1)
∗calculation by 2-tailed paired student t test
∗∗calculation by 2-tailed unpaired student t-test.
In three patients (Group 1), the EHG signal was recorded
before (62 bursts analyzed in total) and 15 minutes (time
expected that eﬀect of nifedipine will occur) after adminis-
tration of nifedipine (53 bursts analyzed in total). As shown
in Table 2 (group 1), averaging the results in these three
patients, a signiﬁcant 7.2% (P<. 05) decrease in PSD peak
frequency was observed (Figure 3).
In three other patients (Group 2), a comparison was
made between the EHG signal recorded within 24 hours
after starting treatment with nifedipine (56 bursts analyzed
in total) and the EHG signal recorded 1 day after ﬁnishing
tocolytic treatment after the 6-day period of treatment (63
bursts analyzed in total). Also in this case, a signiﬁcant
(P<. 05) decrease in PSD peak frequency was observed in
all patients (Table 2,G r o u p2 ) .O na v e r a g e ,t h eP S Dp e a k
frequency decreased of 6.7%.
Finally, from the eight patients in which the EHG was
recorded (Group 3), three patients delivered within 1 week
after treatment with nifedipine (Subgroup 3.2). Frequency
analysis of the signals recorded from these patients (3
patients, 56 bursts analyzed in total), to those patients
delivering after more than 1 week (Subgroup 3.2, 5 patients,
98 bursts analyzed in total), showed, on average, a higher
fP for Subgroup 3.1 as shown in Table 2. However, the
signiﬁcance of this diﬀerence was poor (P = .46).
4. Discussion
The devices and methods currently used for predicting
preterm delivery, such as vaginal examination, tocody-
namometer, fetal ﬁbronectin, and ultrasound measurement
of cervical length, do not provide accurate diagnosis or
prediction of preterm labor [25]. Intrauterine pressure
cathetersarereliablebutlimitedbytheirinvasivenessandthe
need for ruptured membranes. External uterine monitors,
such as tocodynamometers, are uncomfortable, inaccurate,
and depend on the personal interpretation of the examiner.
Biological tests, such as fetal ﬁbronectin, can be used as a
prognostic marker, although with poor positive predictive
values [5]. Even cervical length changes may not be an
accurate indicator of true labor, as a large percentage of
women with established cervical change do not deliver
preterm even without tocolytic treatment [26].
As current methods are not capable of discriminating
contractions, most obstetricians either treat all patients
having preterm contractions or wait for cervical change.
Delay in the diagnosis of preterm labor may result in a lower
eﬃcacy of tocolytic drugs [27, 28], while giving tocolysis to
all patients exhibiting uterine activity is not free of risks for
mother and fetus [21, 28, 29].
Uterine contractions are the direct consequence of the
generation and propagation of electrical activity at theObstetrics and Gynecology International 5
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Figure 2: Tocographic and EHG recording of a patient with
preterm uterine contractions. The ﬁgure shows an example of the
temporal correlation between the uterine electrical and mechanical
activity.
myometrium [6, 7]. It has been demonstrated that the
EHG signal recorded on the skin surface is representative of
the electrical activity initiating the mechanical contraction
of the uterus [7]. Being a measure of the ﬁrst cause
of a contraction, the EHG signal is potentially the best
predictor of delivery. Furthermore, it is noninvasively and
can therefore be employed for both singleton and multiple
gestations during pregnancy and delivery.
For the prediction of labor by electrohysterography
previous studies mainly focused on the analysis of the
frequency properties of the EHG signal [8, 9, 14, 15].
There is general agreement that the peak frequency
derived from the PSD of the signal increases as the
measurement-to-delivery time interval decreases [13, 16].
In particular, Buhimschi et al. [12] detected a signiﬁcant
shift from low to high PSD peak frequency in nonlaboring
preterm patients as compared to laboring preterm patients.
D o r e te ta l .[ 11] performed a study in rats and showed the
PSD peak frequency to be the earliest change to occur in the
EHG signal as preterm delivery approached.
The shift of the EHG signal spectral content to higher
frequencies can be explained by the underlying physiol-
ogy. The frequency of action potentials within a burst is,
in fact, a direct measure of the rate of the depolariza-
tion/repolarization process in the myometrial cells, a process
governed by calcium ion-inﬂux across ion channels [30].
When modiﬁcations in the ion channels of the myometrial
cell plasma membrane initiate labor, the uterus becomes
more excitable [30, 31], the signal propagation distance
and contraction strength increase, and, as a result, higher
frequencies within bursts of activity [13, 16]a r ee x p e c t e d .
Nifedipine is a calcium channel blocker. Therefore, it can
be expected to act directly on the propagation of uterine
activity. Lower frequencies within the EHG bursts after
tocolytics can be associated to a lower level of electrical
activity propagation and, ultimately, to the eﬀectiveness of
the treatment. The majority of tocolytic agents attempt
to paralyze the myometrium, without addressing the root
stimulusofpretermlaborinacause-speciﬁcway.Conversely,
nifedipine acts by inhibiting the inﬂux of calcium ions
through the cell membrane and the release of intracellular
calcium from the sarcoplasmatic reticulum. As a result,
a decrease in intracellular free calcium occurs and leads
to the inhibition of myosin light-chain kinase-mediated
phosphorylation, which is calcium-dependant, and inducing
a relaxation of the myometrium [32].
Moreover, nifedipine can be a preferable treatment for
patients at risk for preterm delivery because it can be
administered by oral route at any gestational age and severe
side eﬀects are reported to be very rare [20].
In the present study, the PSD peak frequency decreased
in all patients after treatment with nifedipine, also for those
patients close to delivery. The same results were obtained
by analyzing the EHG signal of patients who were recorded
within 24 hours of ﬁrst treatment compared to their EHG
signal after end of treatment.
A disadvantage of this study is that there is no control
group. However, all of the patients we included in the study
were at high risk for delivering very preterm.
The PSD fP tendency highlighted in the present study
suggests that nifedipine can be an eﬀective tocolytic agent for
inhibiting electrical activity propagation and therefore the
eﬀectiveness of uterine contraction when occurring preterm.
Inthiscase,theultimategoalisinfactdelayingthedeliveryin
order to allow medical intervention or, in the most desirable
case, to reach the term of pregnancy.
In the present study, three patients delivered in 1 week,
even if they had been treated with nifedipine. All these
women had an asymptomatic urinary tract infection. It is
well established that treatment with antibiotics is associated
with prevention of preterm birth [33]. In our study, four
of the ﬁve patients were treated with antibiotics and two of
them did not deliver within one week. The eﬀectiveness of
tocolytics in the presence of urinary tract infections needs
further to be deﬁned.
The reason of the failure of tocolytics in preventing
preterm delivery is still an unsolved issue for gynecologists.
However, it has been suggested that the eﬀectiveness of
tocolytics is highly dependent on early initiation of the ther-
apy. Therefore, timely recognition of the process leading to
thedeliveryisfundamental.Garﬁeldetal.[18]andLinhartet
al. [26] demonstrated, in fact, that parturition is a two-step
process consisting of a conditioning (preparatory) phase,
followed by active labor. During the conditioning phase,
thereisaprogressionofuterinecontractilityfromaninactive
to an active state. In the myometrium, the preparatory
process involves changes in transduction mechanisms and
the synthesis of several new proteins. At some point of the
conditioning step, the process becomes irreversible and leads
to active labor and, ultimately, to delivery [18]. It is known6 Obstetrics and Gynecology International
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Figure 3: Example of preprocessed EHG signal (upper plot) before (left) and after (right) nifedipine treatment. The corresponding power
spectral densities before (left) and after (right ) nifedipine treatment are depicted in the bottom part of the ﬁgure with an indication of the
peak frequency fP.
thatagentsusedtointerveneinlabormaybeofgreatestvalue
during the preparatory phase in the progression to delivery
[1]. Therefore, it could be suggested that the women in this
study who failed to respond to therapy were treated too late
and that during the EHG recording, an irreversible change to
the active phase of labor might already have occurred.
On average, the women who did not respond to the
therapy and delivered within one week from the measure-
ment showed a higher fP than the other patients. However,
not all patients within one week from delivery showed
higher fP than the rest; ﬁnding a cut-oﬀ value for an
accurate classiﬁcation of the two populations was therefore
not possible. Due to the limited size of the study population,
these preliminary results, even if obtained by analyzing a
large number of bursts, might be aﬀected by the diﬀerent
treatment-to-measurement time.
We showed that the PSD peak frequency decreased in all
women after treatment with nifedipine, although, due to the
small number of women in the study and variable times of
EHG recording (in ﬁve of the eight women, EHG recordings
could only be made after the start of nifedipine treatment),
this could not be linked with a signiﬁcant increase in time to
delivery.
Previousstudiesonamoreextendeddatabaseonanimals
and women not treated with tocolytics concluded that the
peak frequency derived from the PSD of the EHG signal
increases as the measurement-to-delivery interval decreases
[17]. Noticeably, these conclusions were also mostly derived
by mean diﬀerences for all the patients. However, ultimately,
due to a poor signiﬁcance of the diﬀerence, a cut-oﬀ value of
peak frequency has not been found yet. Therefore, further
studies are required in order to develop methods that canObstetrics and Gynecology International 7
reliably diﬀerentiate the uterine status of labor. Longitudinal
studies in pregnant women could support the determination
of the EHG properties related to the electrophysiological
process leading to preterm labor. Further research on the
diﬀerentiation of the uterine electrical activity in the non-
prepared state before labor and the active state of labor
would be necessary; objective criteria to evaluate the state
of the uterine preparedness for labor can in fact improve
management of preterm labor.
5. Conclusion
In this study, the eﬃcacy of nifedipine as a tocolytic drug on
the uterine activity was evaluated by monitoring and analysis
of the EHG signal. Treatment with nifedipine leads to a
statistically signiﬁcant shift to lower PDS peak frequency in
theEHG.As thePDSpeakfrequencyis expected torise when
delivery approaches, from these preliminary results, it could
beconcludedthatnifedipineisaneﬀectivetocolyticagentfor
suppressing preterm contractions. However, further studies
are needed to relate the decrease in the myometrium
electrical activity to the physiological eﬀects leading to the
eﬀectiveness of the tocolitic treatment.
Even with accurate tocolysis, some patients do not
respond to therapy and preterm delivery cannot not be
inhibited. In these patients, an irreversible change to the
active phase of labor has probably occurred. As tocolytic
agents may be more eﬀective during certain periods in the
progression to delivery, it is important to develop methods
that could reliably diagnose the risk of preterm birth at early
stages.
This study conﬁrmed that the EHG signal analysis is a
reliable technique for non-invasive monitoring the uterine
contraction and has great potential for predicting labor,
especially for patients at high risk for preterm delivery.
However, considering also the previous literature on the
topic, our results suggest that the analysis of the EHG signal
frequency alone may not provide a universal cut-oﬀ value for
assessingwhethertheirreversibleprocessleadingtolaborhas
already started or not. Since the spreading of the electrical
activity through the myometrium is the ﬁrst cause of labor,
the analysis of the EHG signal propagation, for example, in
terms of direction and velocity [34–36], might provide an
important contribution to the development of methods that
can objectively evaluate the state of the uterine preparedness
for labor and to identify the patients at risk for preterm
labor.
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